NDATOPICALSOLUTION
Approved
Aug 1985
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
5/8 — Partial
EXELDERM (sulconazole nitrate) by Journey Medical is clinical pharmacology sulconazole nitrate is an imidazole derivative that inhibits the growth of the common pathogenic dermatophytes including trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum, and microsporum canis. Approved for tinea cruris, tinea corporis caused by trichophyton rubrum, trichophyton mentagrophytes and 2 more indications. First approved in 1985.
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EXELDERM (sulconazole nitrate) is a topical imidazole antifungal solution approved in 1985 for treating tinea cruris and tinea corporis caused by dermatophytes including Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum, and Microsporum canis. The drug works by inhibiting fungal growth through disruption of sterol biosynthesis. It also shows activity against Malassezia furfur (tinea versicolor) and certain gram-positive bacteria.
$0.111MPart D
LOE ApproachingDeclining
Minimal commercial activity with only $111K in Part D spending reflects a legacy product with small team; expect consolidation or portfolio rationalization.
Mechanism of Action
CLINICAL PHARMACOLOGY Sulconazole nitrate is an imidazole derivative that inhibits the growth of the common pathogenic dermatophytes including Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis. It also inhibits the organism responsible for tinea…
Indications (5)
Worked on EXELDERM at Journey Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.